The effectiveness of BCG and interferon against non‐muscle invasive bladder cancer: a New Zealand perspective

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|S3|54-60

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.S3, 2015-10, pp. : 54-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Significance of Random Bladder Biopsies in Non-Muscle Invasive Bladder Cancer

By  

Current Urology, Vol. 7, Iss. 2, 2013-10 ,pp. : 57-61

Karger

Access to resources Recommend Favorite

Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer

By  

Current Urology, Vol. 6, Iss. 3, 2012-12 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Clinical and Pathological Prognostic Factors for Recurrence, Progression and Mortality in Non-Muscle Invasive Bladder Cancer: A Meta-Analysis

By  

Current Urology, Vol. 3, Iss. 3, 2009-10 ,pp. : 113-123

Karger

Access to resources Recommend Favorite

Non‐muscle invasive bladder cancer and bacillus Calmette‐Guerin treatment: a review of the literature

By  

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol. 9, Iss. 2, 2015-07 ,pp. : 57-68

John Wiley & Sons Inc

Access to resources Recommend Favorite